AIFF Firefly Neuroscience, Inc.
Company Analysis
Latest News
🔴 Firefly Neuroscience is trading 7.03% down today after profit-taking following 37.62% rally
Firefly Neuroscience is trading 7.03% down at $1.19 amid profit-taking and volatility following its sharp prior-session advance. - It closed at $1.28 on...
🔴 Firefly Neuroscience is trading 13.27% down in pre-market after a 37.62% rally
Firefly Neuroscience is trading at $1.11, down -13.27%, after a 37.62% rally during the September 17 regular session; no confirmed overnight catalyst has been...
🔴 Firefly Neuroscience is trading 10.94% down in after-hours trading; Radial collaboration announced
Firefly Neuroscience is trading 10.94% down at $1.14 after closing at $1.28 on September 17, 2026, with no confirmed specific catalyst for the after-hours...
Firefly Neuroscience Lands Its Biggest Distribution Deal Yet — But Can a $17 Million Company Turn a Partnership Into Real Revenue?
Shares of Firefly Neuroscience jumped 14% to $1.06 Wednesday morning after the micro-cap brain-diagnostics company announced it will embed its FDA-cleared...
🟢 Firefly Neuroscience is trading 13.97% up today after announcing strategic collaboration with Radial
Firefly Neuroscience is trading 13.97% up at $1.06 after announcing a strategic collaboration with Radial on September 17, 2026. - The companies plan to...
🟢 Firefly Neuroscience is trading 6.44% up in pre-market as Nasdaq Composite rises 1.06%
Firefly Neuroscience is trading 6.44% up at $0.99, primarily as a broader pre-market recovery lifted major U.S. indices, including the Nasdaq Composite, up...
🔴 Firefly Neuroscience is trading 5.4% down today; catalyst remains uncertain
Firefly Neuroscience is trading 5.4% down at $0.95, with no clearly identifiable company-specific announcement explaining the September 16, 2026 decline. -...
🟢 Firefly Neuroscience is trading 5% up in pre-market with no clearly identifiable company-specific catalyst
Firefly Neuroscience is trading 5% up at $1.05 in pre-market on September 16, 2026, with no clearly identifiable company-specific catalyst. - Recent coverage...
AIFF Announces CFO Termination, Appoints New Chief Accounting Officer
Firefly Neuroscience, Inc. (AIFF) announced the termination of Paul Krzywicki as Chief Financial Officer and the appointment of Jessica Paz as the new Chief...
Firefly Neuroscience Terminates CFO, Names Jessica Paz Chief Accounting Officer
Firefly Neuroscience terminated Chief Financial Officer Paul Krzywicki, effective September 24, 2026. The company confirmed the decision did not involve...
🟢 Firefly Neuroscience is trading 6.54% up in pre-market despite no clear company-specific catalyst
Firefly Neuroscience is trading at $1.14 (+6.54%) with no credible company-specific catalyst identified in overnight coverage. - No credible September 14,...
🔴 Firefly Neuroscience is trading 5.4% down today as healthcare ETF XLV drops 2.19%
Firefly Neuroscience is trading 5.4% down at $1.05, with the decline most consistent with healthcare-sector pressure as insurance concerns weigh on hospitals...
🟢 Firefly Neuroscience is trading 5.1% up today amid healthcare sector’s 1.37% rise
Firefly Neuroscience is trading 5.1% up at $1.14 after healthcare stocks gained during the September 3, 2026 regular session. - The healthcare sector rose...
🔴 Firefly Neuroscience is trading 5.91% down today as broader markets weaken
Firefly Neuroscience is trading 5.91% down now at $1.05 as broader markets weaken amid Middle East tensions, higher oil prices, rising yields, and renewed rate...
🟢 Firefly Neuroscience is trading 5.56% up today with no confirmed catalyst identified
Firefly Neuroscience is trading 5.56% up at $1.14 after opening-market gains on August 31, 2026, with no confirmed company-specific announcement or reliable...
🔴 Firefly Neuroscience is trading 5.56% down in pre-market, with no confirmed catalyst identified
Firefly Neuroscience is trading at $1.02 (-5.56%), with no confirmed company-specific catalyst identified for the August 28, 2026 pre-market decline. - The...
🟢 Firefly Neuroscience is trading 7.84% up today amid stronger AI and technology-market sentiment
Firefly Neuroscience is trading at $1.10, up 7.84%, alongside stronger AI and technology-market sentiment on August 27, 2026. - The NASDAQ Composite is up...
🔴 Firefly Neuroscience is trading 5.56% down today with no clear company-specific catalyst
Firefly Neuroscience is trading at $1.02 (-5.56%), with no clear company-specific catalyst identified for August 24, 2026. - Recent disclosures include...
🔴 Firefly Neuroscience is trading 6.05% down in pre-market — while no clear company-specific catalyst was identified
Firefly Neuroscience is trading at $1.01, down 6.05%, after no clear company-specific catalyst was identified for August 21, 2026. • Recent disclosures...
🔴 Firefly Neuroscience is trading 7.31% down in pre-market with no identified company-specific announcement
Firefly Neuroscience is trading 7.31% down at $1.01 after closing at $1.09 on August 18, 2026, with no credible company-specific announcement dated August 19,...